Source: Web Search Revision Year: 2021 Publisher: sanofi-aventis south africa (pty) ltd, 2 Bond Street, 1685, Midrand, SA
BUSCOPAN COMPOSITUM 20 mg/2,5 g injection.
| Pharmaceutical Form |
|---|
|
A clear, slightly yellowish solution free from physical impurities. |
Each 5 ml ampoule contains:
Metamizole sodium monohydrate: 2500 mg
Hyoscine butylbromide: 20 mg
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Butylscopolamine |
Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. |
|
| Metamizole sodium |
Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid. |
| List of Excipients |
|---|
|
Water for injection |
Ampoules of 5 ml in boxes of three ampoules.
sanofi-aventis south africa (pty) ltd, 2 Bond Street, 1685, Midrand, SA
E/11.2/504
30 March 1994
| Drug | Countries | |
|---|---|---|
| BUSCAPINA COMPOSITUM | Spain, Mexico |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
